USPTO serial 86463776
ASSURE
Reviewed by CopyMark Law Group
Reg. 5807079Status 710
- Filing date
- Status date
- Registration date
- Jul 16, 2019
- Examiner
- SCHMIDT, JOHN JOSEPH
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with ASSURE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Otsuka America Pharmaceutical, Inc.
Rockville, MD, US
Other trademarks owned by Otsuka America Pharmaceutical, Inc.
Otsuka America Pharmaceutical, Inc.
Rockville, MD, US
Other trademarks owned by Otsuka America Pharmaceutical, Inc.
Otsuka America Pharmaceutical, Inc.
Rockville, MD, US
Other trademarks owned by Otsuka America Pharmaceutical, Inc.
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
B. Brett Heavner
B. BRETT HEAVNER FINNEGAN, HENDERSON, FARABOW, GARRETT AND DUNNER,901 NEW YORK AVE NWWASHINGTON, DC 20001-4432UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 016 | Printed materials, namely, brochures, pamphlets and posters about patient support for central nervous system diseases, disorders and treatment and vasopressin receptor antagonist responsive diseases, disorders, and treatment | SECTION 8 - CANCELLED | Nov 24, 2014 |
| 035 | Promoting awareness of patient support offerings for central nervous system diseases, disorders and treatment and vasopressin receptor antagonist responsive diseases, disorders, and treatment; discharge planning support, namely, providing consumer information to patients about health care plan options, products and programs in the field of managed care and state and federal medical care programs for central nervous system diseases, disorders and treatment and for vasopressin receptor antagonist responsive diseases, disorders, and treatment | SECTION 8 - CANCELLED | Nov 24, 2014 |
| 036 | Providing financial information about reimbursement for medical expenses for patients with central nervous system diseases and disorders and vasopressin receptor antagonist responsive diseases and disorders; providing insurance information about medical benefit verification and prior authorization services for patients with central nervous system diseases and disorders and vasopressin receptor antagonist responsive diseases and disorders; providing insurance information about medical records coding, billing, and compliance for patients with central nervous system diseases and disorders and vasopressin receptor antagonist responsive diseases and disorders | SECTION 8 - CANCELLED | Nov 24, 2014 |
| 041 | Educational services, namely, conducting educational programs and providing courses about central nervous system diseases, disorders and treatment; on-line publishing of electronic publications; on-line journals, namely, blogs about central nervous system diseases, disorders and treatment and vasopressin receptor antagonist responsive diseases, disorders, and treatment | SECTION 8 - CANCELLED | Nov 24, 2014 |
| 044 | Providing patient support in the nature of information about the location of medical treatment facilities for central nervous system diseases and disorders and for vasopressin receptor antagonist responsive diseases and disorders; providing medical information to medical professionals in the field of treatment of central nervous system diseases and disorders and of vasopressin receptor antagonist responsive diseases and disorders; providing a website for medical professionals featuring medical information in the field of treatment of central nervous system diseases and disorders and of vasopressin receptor antagonist responsive diseases and disorders | SECTION 8 - CANCELLED | Nov 24, 2014 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Otsuka America Pharmaceutical, Inc.
- Other trademarks owned by Otsuka America Pharmaceutical, Inc.
- Other trademarks owned by Otsuka America Pharmaceutical, Inc.
- Other trademarks in Class 016
- Other trademarks in Class 035
- Other trademarks in Class 036
- Other trademarks in Class 041
- Other trademarks in Class 044
- Similar marks named ASSURE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 30, 2026 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Jul 16, 2024 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Jul 16, 2019 | EXPT | EXPARTE APPEAL TERMINATED | — |
| Jul 16, 2019 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 8, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 11, 2019 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Jun 9, 2019 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| May 17, 2019 | JURT | JURISDICTION RESTORED TO EXAMINING ATTORNEY | — |
| Mar 25, 2019 | GEA1 | NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED | — |
| Mar 25, 2019 | GECD | ACTION DENYING REQ FOR RECON E-MAILED | — |
| Mar 25, 2019 | CNCF | SU - ACTION CONTINUING FINAL - WRITTEN | — |
| Mar 4, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 4, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 25, 2019 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Feb 20, 2019 | GNS1 | NOTIFICATION OF SUBSEQUENT FINAL EMAILED | — |
| Feb 20, 2019 | GNCF | CONTINUATION OF FINAL REFUSAL E-MAILED | — |
| Feb 20, 2019 | CNCF | SU - ACTION CONTINUING FINAL - WRITTEN | — |
| Jan 31, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 31, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 28, 2019 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Jan 28, 2019 | EXPI | EX PARTE APPEAL-INSTITUTED | — |
| Jan 28, 2019 | JURT | JURISDICTION RESTORED TO EXAMINING ATTORNEY | — |
| Jan 28, 2019 | EXAF | EXPARTE APPEAL RECEIVED AT TTAB | — |
| Jul 27, 2018 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Jul 27, 2018 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jul 27, 2018 | CNFR | SU - FINAL REFUSAL - WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jul 5, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 5, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 29, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 27, 2018 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Dec 29, 2017 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 29, 2017 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 29, 2017 | CNRT | SU - NON-FINAL ACTION - WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 8, 2017 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Dec 1, 2017 | IROA | RESPONSE TO ITU OFFICE ACTION ENTERED | — |
| Dec 1, 2017 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 27, 2017 | INCS | ITU OFFICE ACTION ISSUED FOR STATEMENT OF USE | — |
| Nov 20, 2017 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Nov 8, 2017 | IUAF | USE AMENDMENT FILED | — |
| Nov 8, 2017 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Sep 29, 2017 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Sep 27, 2017 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Sep 27, 2017 | EXT1 | SOU EXTENSION 1 FILED | — |
| Sep 27, 2017 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Mar 28, 2017 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jan 31, 2017 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 31, 2017 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 11, 2017 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 28, 2016 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Dec 24, 2016 | ALIE | ASSIGNED TO LIE | — |
| Dec 10, 2016 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 19, 2016 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 18, 2016 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 18, 2016 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 18, 2016 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 18, 2016 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 18, 2016 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 27, 2016 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Apr 20, 2016 | ALIE | ASSIGNED TO LIE | — |
| Oct 1, 2015 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Oct 1, 2015 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Oct 1, 2015 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Sep 17, 2015 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 16, 2015 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 16, 2015 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 19, 2015 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 19, 2015 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 19, 2015 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 12, 2015 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 4, 2014 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Dec 3, 2014 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 27, 2014 | NWAP | NEW APPLICATION ENTERED | — |